Ipilimumab-induced severe meningoradiculitis.

Lacour, Morgane; Grangeon, Lou; Flament, Jasmine; Duval-Modeste, Anne-Bénédicte; Zaréa, Aline; Guillaume, Maxime; Lefaucheur, Romain

Lacour, Morgane; Grangeon, Lou; Flament, Jasmine; Duval-Modeste, Anne-Bénédicte; Zaréa, Aline; Guillaume, Maxime; Lefaucheur, Romain.

Afiliación

Lacour M; Department of Neurology, Rouen University Hospital and University of Rouen, France.
Grangeon L; Department of Neurology, Rouen University Hospital and University of Rouen, France.
Flament J; Department of Dermatology, Rouen University Hospital and University of Rouen, France.
Duval-Modeste AB; Department of Dermatology, Rouen University Hospital and University of Rouen, France.
Zaréa A; Department of Neurology, Rouen University Hospital and University of Rouen, France.
Guillaume M; Department of Neurology, Rouen University Hospital and University of Rouen, France.
Lefaucheur R; Department of Neurology, Rouen University Hospital and University of Rouen, France. Electronic address: romain.lefaucheur@chu-rouen.fr.

J Clin Neurosci ; 62: 246-247, 2019 Apr.

Article en En | MEDLINE | ID: mdl-30598268

Palabras clave

Adverse effect; Immune checkpoint inhibitors; Ipilimumab; Meningoradiculitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Neurosci Asunto de la revista: NEUROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google